LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 16,481 pages found matching <a href=""></a>- Girl Perseveres Through Pains of Stevens Johnson Syndrome
Dec-8-11 New Orleans, LA A family from New Orleans, Louisiana, is telling its tragic story as a way to educate families and doctors about a rare condition known as Stevens Johnson Syndrome (SJS), according to WWLTV News . The news source reported that Jasmin Bindom, a junior at St. Mary's Academy, was getting ready to shop for graduation party dresses when... - Health Organizations Issue Warnings about Use of Terbutaline during Pregnancy
Dec-7-11 Baltimore, MD The US Food and Drug Administration (FDA) is not the only health organization to issue a warning about terbutaline side effects . In fact, the American College of Obstetricians and Gynecologists has also recommended against long-term use of terbutaline during pregnancy. Specifically, the organization warned about prolonged use of terbutali... - Takeda May Face 10,000 Lawsuits in US Over Actos Bladder Cancer
Dec-7-11 Washington, DC Takeda Pharmaceutical Co., Asia's biggest drugmaker, could face up to 10,000 lawsuits in US courts over Actos bladder cancer allegations, according to Bloomberg . The news source reported that the high number of cases that could be brought forward has led to a group of judges meeting to decide whether these lawsuits should be consoli... - Abbott Laboratories Faces Whistleblower Lawsuit Concerning Depakote
Dec-2-11 Chicago, IL Abbott Laboratories, maker of Depakote faces a whistleblower lawsuit alleging the company illegally marketed its epilepsy medication. According to the Chicago Tribune (11/13/11), a whistleblower lawsuit was filed in 2010 by Thomas Spetter Jr, who alleges he was told to market Depakote, an epilepsy drug, for off-label uses. Specifical... - A Woeful Tale of Two DePuy Hips
Dec-6-11 Venice, NJ "It's hard to live with constant, constant pain." So says a Cork, Ireland woman who has suffered through no fewer than three operations to her one hip since a troublesome DePuy Hip Replacement system was removed from her body about a year before the worldwide recall of the DePuy hip ASR component. Juergen Schaberick, a native of Frankfurt wh... - Settlement Over Devices Similar to Zimmer Knee Implants Led to Doctor-Consulting Pay Cuts
Dec-6-11 Washington, DC The largest manufacturers of products similar to Zimmer knee implants scaled back payments to orthopedic surgeons after settling a 2007 US lawsuit that charged these companies with providing kickbacks, according to a report by researchers, Bloomberg noted. According to the news source, researchers analyzed data that was released by... - Family That Lost their Mother Awarded $20.6 Million
Salem, MA: The widower and child of a young woman who died as a result of a defective inflatable pool slide purchased from Toys "R" Us have been awarded a $20.6 million settlement this week by the judge hearing the personal injury lawsuit. The accident that took Robin Aleo's life happened five years ago, when she was just 29 years old. She had an... - FDA Warns Consumers about Counterfeit Alli
Washington, DC: The U.S. Food and Drug Administration is today warning consumers about a counterfeit and potentially harmful version of Alli 60 mg capsules (120 count refill kit). Preliminary laboratory tests conducted by GlaxoSmithKline (GSK)—the maker of Alli, the FDA approved over-the-counter weight-loss product — revealed that the c... - Report Cites Hip Implant Failures
Dec-1-11 Boston, MA A new report in the British Medical Journal indicates that all-metal hip implant failures may be just as common as traditional hip replacement failures. Furthermore, the metal-on-metal hip implants may be less safe than traditional hip implants and may have a higher hip revision surgery rate. Hip implant lawsuits have been filed against th... - Are Orlistat Benefits Worth the Alli Side Effects?
Dec-5-11 Helena, MT When it comes to losing weight, many people are willing to risk minor Alli side effects so they can achieve the results they want. But are the benefits worth the reported Alli side effects? Public Citizen, a public advocacy organization, says the risks of drugs that contain orlistat (the generic version of Alli) are far too high, and the ben... - First Yasmin Birth Control Pills Lawsuit Launched in Canada
Dec-5-11 Toronto, Canada The relatives of a woman who died in Toronto, Ontario, after taking Yasmin birth control pills have filed the first individual civil lawsuit against the drug manufacturer in Canada, according to CBC News . The news source reported that Vicky Caprice Meserau, a 26-year-old Toronto resident, died in 2009 of a large pulmonary embolism... - California Overtime: Panera 'Breadwinners' Await Settlement Approval
Nov-30-11 San Bernardino, CA Bakery-cafe employees may be the breadwinners in California Overtime class-action lawsuits filed against Panera Bread Co. Class-action lawsuits filed in 2009 and 2011 claimed the franchise failed to pay overtime and provide breaks at some company or franchised stores in California, which are violations of the California Labor Law. ... - Lingering Radiation Levels Only One Concern with Recalled CardioGen-82
Dec-4-11 Sarasota, FL The concern for radiation exposure in relation to the recent recall of CardioGen-82 by Italian manufacturer Bracco Diagnostics is obvious. What isn't, are the ancillary concerns—including travel across international borders—at a time when the world remains understandably vigilant with regard to terrorism. Medically, there is... - Lawsuits Filed against Makers of Fentanyl Patches
Dec-3-11 New York, NY Fentanyl lawsuits have been filed against the makers of fentanyl patches , alleging the patches are responsible for the death and injury of loved ones. Although the fentanyl patches—sometimes sold under the Duragesic patch brand—are used to treat pain, they are very strong medications and some serious fentanyl side effects have... - Asbestos Drilling May Have Led to Death of UK Man
Dec-3-11 Manchester, England The death of John Shiers from cancer, which has been alleged to come from asbestos drilling , has raised questions about housing providers across the United Kingdom, Inside Housing reported. This problem has been reported on both sides of the Atlantic, as officials from housing agencies have noted the issues related to this alle... - Unum Is Still a Pain in the Back
Nov-28-11 Baton Rouge, LA Despite the thousands upon thousands of lawsuits that Unum was made to settle by the courts after its policy holders' denials were reversed, it would appear that the giant health provider is still denying policy holders with back injuries. Even though in 2008 the US Court of Appeals of the Second District found in favor of the plaint... - Oklahoma SSDI Statistics: Apply with an Attorney at Your Side
Nov-23-11 Tulsa, OK Given that the number of people who apply for social security benefits and are initially denied is increasing, it makes sense to have an experienced SSDI attorney help with your application. More than 60 percent of Oklahoma residents who apply for Oklahoma SSDI are denied benefits at the first stage of the application process. And taking i... - High-Risk Investments Like Giving a Dragster to a Granny
Dec-2-11 New York, NY The requirement and responsibility for any financial advisor to be sensitive to an investor's risk tolerance is akin to a mechanic performing an appropriate fix on an elderly widow's staid Crown Victoria. Thus, the allegations surrounding Bill Tatro and Eagle Steward are not far removed from a scenario that sees our kindly widow getting he... - Makers of Actos Facing Over 10,000 US Bladder Cancer Lawsuits
Dec-1-11 New York, NY Takeda Pharmaceutical Co., the maker of the diabetes medication Actos (poiglitizone), could be facing as many as 10,000 lawsuits in the US--lawsuits that allege the drug causes bladder cancer. Currently, a group of US justices are deciding whether or not the cases should be consolidated. Earlier this year Takeda pulled Actos from Germ... - J&J Agrees to Pay $85 Million for Natrecor Misbranding
Washington, DC: Johnson & Johnson subsidiary, Scios, has agreed to pay $85 million to settle a criminal misdemeanour charge of misbranding its drug Natrecor, used to treat heart failure. The charges stemmed from a Justice Department probe into allegations brought by a whistleblower that Scios was promoting Natrecor for off-label use as a routine,...